Metabolic Research

Tirzepatide Research Guide

Research Overview

Tirzepatide is a synthetic, fatty-acid-modified peptide that acts as a dual agonist at the glucose-dependent insulinotropic polypeptide receptor (GIPR) and the glucagon-like peptide-1 receptor (GLP-1R). It has been studied extensively in preclinical and clinical metabolic research as a first-in-class co-agonist of two incretin pathways. This is a research compound and is not intended for human consumption.

Structural & Class Overview

Single-chain incretin-mimetic peptide (39 residues) with a C20 fatty diacid moiety enabling albumin binding and extended half-life. Structurally related to native GIP; functions as an imbalanced dual GIPR/GLP-1R agonist, both receptors belonging to the class B G-protein-coupled receptor family.

General Research Interest

Research interest includes dual incretin-receptor signaling and biased agonism, glucose-dependent insulin secretion pathways in laboratory models, hepatic lipid handling in preclinical steatosis models, receptor desensitization kinetics, and comparative pharmacology against selective GLP-1R agonists.

Storage Considerations

Typically supplied as a lyophilized powder. General research handling favors storage of lyophilized material cold and protected from light and moisture; reconstituted solutions are generally kept refrigerated and used within a limited window. For laboratory research handling only.

Testing & Quality Considerations

Quality considerations for a research peptide include HPLC purity analysis, mass-spectrometry identity confirmation of the expected molecular mass, and verification against a batch Certificate of Analysis (COA) prior to use.

References

  1. Tirzepatide — DrugBank DB15171
  2. Tirzepatide — PubChem CID 156588324
  3. Structural determinants of dual incretin receptor agonism by tirzepatide (PMC)

References are provided for scientific context. Linked sources are independent and not affiliated with iNGEN MD.

Research Use Only — Not For Human Consumption. All products sold by iNGEN MD are intended strictly for in-vitro laboratory and scientific research purposes only. These products are not approved by the FDA and are not intended for human or veterinary use, diagnosis, treatment, cure, or prevention of any disease. By purchasing, you confirm you are a qualified researcher aged 18 or older, acting in compliance with all applicable laws. iNGEN MD assumes no liability for misuse.